Short QT syndrome. Update on a recent entity

Archives of Cardiovascular Diseases

Volumn 101, Issue 11-12, 2008, Pages 779-786

  Maury, Philippe ^a   Extramiana, Fabrice ^b   Sbragia, Pascal ^c   Giustetto, Carla ^d   Schimpf, Rainer ^e   Duparc, Alexandre ^a   Wolpert, Christian ^e   Denjoy, Isabelle ^b   Delay, Marc ^a   Borggrefe, Martin ^e   Gaita, Fiorenzo ^d  

^a CHU RANGUEIL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HÔPITAL NORD   (France)

^d CARDINAL MASSAIA HOSPITAL   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Idiopathic ventricular fibrillation; Ion channel disorder; QT interval; Short QT syndrome; Sudden death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; IBUTILIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNJ2; POTASSIUM CHANNEL KCNQ1; PROPAFENONE; QUINIDINE; SOTALOL; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; CLINICAL FEATURE; DEFIBRILLATION; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG EFFICACY; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; EXERCISE TEST; GENE MUTATION; GENETIC HETEROGENEITY; HEART ATRIUM FIBRILLATION; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE FIBRILLATION; HUMAN; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PREVALENCE; QT INTERVAL; REVIEW; SHORT QT SYNDROME; SUDDEN DEATH; TREATMENT DURATION; TREATMENT INDICATION;

EID: 58049191106     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.08.009     Document Type: Review

References (37)

1. Wever EFD. Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol 2004;43:1137-44.
2. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiacdeath of the European society of cardiology. Eur Heart J 2001;22:1374-450.
3. Consensus statement of the joint steering commitees of the unexplained cardiac arrest registry of Europe and of the idiopathic ventricular fibrillation registry of the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Circulation 1997;95:265-272.
4. Chevalier P, Touboul P. Les fibrillations ventriculaires idiopathiques. Arch Mal Coeur Vaiss 1999;92:29-36.
5. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. QT interval variables from 24hour electrocardiography and the two-year risk of sudden death. Br Heart J 1993;70:43-8.
6. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: a new clinical syndrome. Cardiology 2000;94:99-102.
7. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome. A familial cause of sudden death. Circulation 2003;108:965-70.
8. Priori S, Pandit SV, Rivolta I, et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005;96:800-7.
9. Bellocq C, Van Ginneken ACG, Bezzina CR, et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004;109:2394-7.
10. Kirilmae A, Uluso RE, Kardesoglu E, Ozmen N, Demilrap E. Short QT interval syndrome: a case report. J Electrocardiol 2005;38:371-4.
11. Maury P, Hollington L, Duparc A, Brugada R. Short QT Syndrome. Should we push the frontier forward? Heart Rhythm 2005;2:1135-7.
12. Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005;16:394-6.
13. Hong K, Piper DR, Diaz-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005;68:433-40.
14. Lu LX, Zhou W, Zhang X, Cao Q, Yu K, Zhu C. Short QT syndrome: a case report and review of the literature. Resuscitation 2006;71:115-21.
15. Wolpert C, Schimpf R, Veltmann C, Giustetto C, Gaita F, Borggrefe M. Clinical characteristics and treatment of short QT syndrome. Expert Rev Cardiovasc Ther 2005;3:611-7.
16. Giustetto C, Di Monte F, Wolpert C, et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006;27:2440-7.
17. Borggrefe M, Wolpert C, Schimpf R, et al. Short QT syndrome: genotype-phenotype correlation. J Electrocardiol 2005;38:75-80.
18. Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M: Short QT syndrome. Cardiovasc Res 2005;67:357-66.
19. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72:23B-5B.
20. Luo S, Tompkins WJ. Parameter evaluation of the inverse power-law spectrum of heart rate. A quantitative approach for ECG arrhythmia evaluation. J Electrocardiol 1994;27: 46-52.
21. Viskin S, Zeltser D, Ish-Shalom M, et al. Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm 2004;1:587-91.
22. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carders of the gene for the long-QT syndrome. N Engl J Med 1992;327:846-52.
23. Rautaharju PM, Warren JW, Calhoun HP. Estimation of QT prolongation. A persistent, avoidable error in computer electrocardiography. J Electrocardiol 1990;23:111-7.
24. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 2004;43:1494-9.
25. Gallagher MM, Magliano G, Yap YG, et al. Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons. Am J Cardiol 2006;98:933-5.
26. Reinig M, Engel T. The shortage of short QTc. Chest 2007;132:246-9.
27. Anttonen O, Junttila MJ, Rissanen H, Reunanen A, Viitasalo M, Huikuri HV. Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 2007;116:714-20.
28. Filipecki A, Trusz M, Lubinski A. Prevalence of very short QT intervals in patients with idiopathic ventricular fibrillation and implanted ICD (abstract). Circulation 2004;110. III-501.
29. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004;109:30-5.
30. Schimpf R, Bauersfeld U, Gaita F, Wolpert C. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2005;2: 416-7.
31. Wolpert C, Schimpf R, Giustetto C, et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 2005;16: 54-8.
32. Extramiana F, Antzelevitch C. Amplified transmural dispersion of repolarisation as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 2004;110:3661-6.
33. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-fonction mutation in familial atrial fibrillation. Science 2003;299:251-4.
34. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905.
35. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005;332:1012-9.
36. Schimpf R, Wolpert C, Bianchi F, et al. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 2003;14:1273-7.
37. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-9.